Intermittent concurrent use of clopidogrel and proton pump inhibitors did not increase risk of adverse clinical outcomes in Chinese patients with coronary artery disease

BACKGROUND: Proton pump inhibitors (PPIs) are frequently prescribed to patients with coronary heart disease (CHD) under antiplatelet therapy to prevent gastrointestinal (GI) bleeding. However, its clinical impact is still under debate, especially in Asian population. This study was undertaken to exp...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:BMC Cardiovasc Disord
Autori principali: He, Wanbing, Shu, Xiaorong, Zhu, Enyi, Deng, Bingqing, Lin, Yongqing, Wu, Xiaoying, Zhou, Zenan, Wang, Jingfeng, Nie, Ruqiong
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2021
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7863361/
https://ncbi.nlm.nih.gov/pubmed/33546595
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12872-021-01884-z
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi